1. Home
  2. Dasatinib
  Subject:

Dasatinib   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
RELATED SUBJECTS:
The publications listed also have these subjects
Tyrosine kinase  5 times
Kinase  5 times
Chronic myelogenous leukemia  5 times
Imatinib  4 times
Tyrosine-kinase inhibitor  2 times
Protein kinase B  2 times
Pleural effusion  2 times
Phosphorylation  2 times
Hypertension  2 times
Estrogen receptor  2 times
Enzyme inhibitor  2 times
Bone marrow  2 times
Apoptosis  2 times
Acute lymphoblastic leukemia  2 times
Xenotransplantation  1 time
Western blot  1 time
Vasoconstriction  1 time
Thrombocytopenia  1 time
T-cell receptor  1 time
Syndrome  1 time
Serotonin  1 time
S100 protein  1 time
Rotenone  1 time
Reactive oxygen species  1 time
Propofol  1 time
Polymerase chain reaction  1 time
Polish language  1 time
Philadelphia  1 time
Pesticide  1 time
Peripheral artery disease  1 time
Pancreatic islets  1 time
Oxidative stress  1 time
Ovarian cancer  1 time
Nucleotide  1 time
Non-small-cell lung carcinoma  1 time
Neutropenia  1 time
Natural killer cell  1 time
NALP3  1 time
Myeloid tissue  1 time
Mutation  1 time
Mouse  1 time
Mechanistic target of rapamycin  1 time
Leukopenia  1 time
Leukemia  1 time
Lectin  1 time
Inflammasome  1 time
Immunotherapy  1 time
Immunoprecipitation  1 time
Immunohistochemistry  1 time
Immunoglobulin M  1 time
Immunoglobulin G  1 time
Immunoglobulin A  1 time
Humoral immunity  1 time
Hepatocyte  1 time
Haplotype  1 time
Growth factor  1 time
Gracilis muscle  1 time
Genetic code  1 time
Gene  1 time
Gefitinib  1 time
Flow cytometry  1 time
Endothelium  1 time
Endoplasmic reticulum  1 time
ELISA  1 time
Crizotinib  1 time
Confidence interval  1 time
Chemotherapy  1 time
Cell-mediated immunity  1 time
Cell cycle  1 time
Carboplatin  1 time
CD34  1 time
Breast cancer  1 time
Blood plasma  1 time
Biomarker  1 time
B cell  1 time
Antioxidant  1 time
Antibody  1 time
Allele  1 time
Adenocarcinoma  1 time
Acid  1 time

Publications tagged with this subject: 14

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors

2. The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report

3. Involvement of c-Abl Kinase in Microglial Activation of NLRP3 Inflammasome and Impairment in Autolysosomal System

4. Src tyrosine kinases contribute to serotonin-mediated contraction by regulating calcium-dependent pathways in rat skeletal muscle arteries

5. Analysis of adverse events associated with dasatinib and nilotinib treatments in chronic-phase chronic myeloid leukemia patients outside clinical trials

6. Ponatinib in Japanese patients with Philadelphia chromosome-positive leukemia, a phase 1/2 study

7. NKG2D gene polymorphisms are associated with disease control of chronic myeloid leukemia by dasatinib

8. Tyrosine kinase inhibitor therapy-induced changes in humoral immunity in patients with chronic myeloid leukemia

9. S100β as a serum marker in endocrine resistant breast cancer

10. Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

11. Propofol enhances BCR-ABL TKIs’ inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression

12. Synergistic tumor suppression by a Perilla frutescens-derived methoxyflavanone and anti-cancer tyrosine kinase inhibitors in A549 human lung adenocarcinoma

13. Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy

14. Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series


Questions?

Drop us a message.